Safety of high doses of low molecular weight heparin (Fragmin) in acute myocardial infarction. A dose - finding study (Q42614369)

reason for preferred rank

3 November 2017

title

Safety of high doses of low molecular weight heparin (Fragmin) in acute myocardial infarction. A dose - finding study (English)

1 reference

https://api.crossref.org/works/10.1016/S0049-3848(05)80007-6

24 October 2022

Safety of high doses of low molecular weight heparin (Fragmin) in acute myocardial infarction. A dose-finding study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1667048

24 October 2022

1 reference

A. Nesvold

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1667048

24 October 2022

F. Kontny

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1667048

24 October 2022

U. Abildgaard

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1667048

24 October 2022

J. Dale

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1667048

24 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1667048

24 October 2022

publication date

1 December 1991

1 reference

full work available at URL

3 November 2017

https://api.elsevier.com/content/article/PII:S0049384805800076?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0049-3848(05)80007-6

https://api.elsevier.com/content/article/PII:S0049384805800076?httpAccept=text/plain

24 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0049-3848(05)80007-6

24 October 2022

1 reference

3 November 2017

volume

64

1 reference

3 November 2017

issue

5

1 reference

3 November 2017

page(s)

579-587

1 reference

Left ventricular thrombus following acute myocardial infarction: a prospective serial echocardiographic study of 96 patients

3 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2805%2980007-6

7 January 2021

Left ventricular mural thrombi complicating acute myocardial infarction. Long-term follow-up with serial echocardiography

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2805%2980007-6

7 January 2021

Incidence of left-ventricular thrombosis after acute transmural myocardial infarction. Serial evaluation by two-dimensional echocardiography

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2805%2980007-6

7 January 2021

Left ventricular thrombosis and cerebrovascular accident in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2805%2980007-6

7 January 2021

Prospective two-dimensional echocardiographic evaluation of left ventricular thrombus and embolism after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2805%2980007-6

7 January 2021

Left ventricular thrombus incidence and behavior studied by serial two-dimensional echocardiography in acute anterior myocardial infarction: left ventricular wall motion, systemic embolism and oral anticoagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2805%2980007-6

7 January 2021

Left ventricular thrombi diagnosed by echocardiography in patients with acute myocardial infarction treated with intracoronary streptokinase followed by intravenous heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2805%2980007-6

7 January 2021

Impact of thrombolytic therapy on left ventricular mural thrombi in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2805%2980007-6

7 January 2021

Comparison of high-dose with low-dose subcutaneous heparin to prevent left ventricular mural thrombosis in patients with acute transmural anterior myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2805%2980007-6

7 January 2021

A low molecular weight heparin compared with unfractionated heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2805%2980007-6

7 January 2021

Anticoagulant effects of two types of low molecular weight heparin administered subcutaneously

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2805%2980007-6

7 January 2021

Simplified chromogenic substrate assay for low molecular weight heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2805%2980007-6

7 January 2021

Dose adjusted heparin treatment of deep venous thrombosis: a comparison of unfractionated and low molecular weight heparin.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2805%2980007-6

7 January 2021

Management of heparin therapy: Controlled prospective trial

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2805%2980007-6

7 January 2021

Pharmacokinetics of intravenously and subcutaneously administered Fragmin in healthy volunteers

13

1 reference

https://api.crossref.org/works/10.1016/S0049-3848(05)80007-6

Intravenous and subcutaneous administration of Fragmin in deep venous thrombosis

24 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/S0049-3848(05)80007-6

24 October 2022

Identifiers

1 reference

3 November 2017

1 reference